Verona Pharma PLC Holding(s) in Company (8462T)
11 January 2017 - 6:00PM
UK Regulatory
TIDMVRP
RNS Number : 8462T
Verona Pharma PLC
11 January 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
1. Identity of the issuer or Verona Pharma Plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------------- ---------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
---------------------------------------------------------------- ------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
---------------------------------------------------------------- ------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
---------------------------------------------------------------- ------------------
An event changing the breakdown of voting rights
---------------------------------------------------------------- ------------------
Other (please
specify):
--------------------------------------------------------- ----- ------------------
3. Full name of person(s) Novo A/S
subject to the
notification obligation:
(iii)
----------------------------------------------------------- -----------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
----------------------------------------------------------- -----------------------
5. Date of the transaction 30 December 2016
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- -----------------------
6. Date on which issuer 10 January 2017
notified:
----------------------------------------------------------- -----------------------
7. Threshold(s) that is/are Above 12%
crossed or
reached: (vi, vii)
----------------------------------------------------------- -----------------------
8. Notified details:
------------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
------------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------------------- -----------------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
------------- -------------------------- ---------------- ---------------- ------------------------- --------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- --------- ----------- ------------ ---------------- ------------ ----------- --------- ---------
Ordinary
Shares
(0.1p)
GB00B06GSH43 221,203,271 221,203,271 323,203,271 323,203,271 12.59%
-------------------------- ---------------- ---------------- ------------ ----------- --------- ---------
B: Qualifying Financial Instruments
------------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ------------------------ ------------------ ----------------------------------------- ------------------
C: Financial Instruments with similar economic effect to
Qualifying Financial Instruments (xv, xvi)
------------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- ----------- --------------- -------------- ------------------------------ -------------------------------
Nominal Delta
--------------- ----------- --------------- -------------- ------------------------------ -------------------- ---------
Total (A+B+C)
------------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------------------- ---------------------------------------------------------------
323,203,271 12.59%
------------------------------------------------------------- ---------------------------------------------------------------
9. Chain of controlled undertakings through which the voting
rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
----------------------------------------------------------------------------------
Proxy Voting:
----------------------------------------------------------------------------------
10. Name of the proxy holder:
-------------------------------------------------------------- ------------------
11. Number of voting rights proxy
holder will cease
to hold:
-------------------------------------------------------------- ------------------
12. Date on which proxy holder will
cease to hold
voting rights:
-------------------------------------------------------------- ------------------
13. Additional information:
-------------------------------------------------------------- ------------------
14. Contact name: Heather Ludvigsen
-------------------------------------------------------------- ------------------
15. Contact telephone number: +45 3527 6576
-------------------------------------------------------------- ------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGGURUGUPMGBU
(END) Dow Jones Newswires
January 11, 2017 02:00 ET (07:00 GMT)
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Apr 2024 to May 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Verona Pharma Plc (London Stock Exchange): 0 recent articles
More Verona Pharma News Articles